Skip to Main Content

Paper Details

Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF.
Am Heart J
4
2021
AF, Patients, Rivaroxaban, SE, atrial fibrillation, patient, patients, rivaroxaban, stroke, systemic embolism, vascular, vascular death, warfarin
Author NameAffiliation
Kenneth W MahaffeyStanford Center for Clinical Research, Stanford University
Jonathan P PicciniDuke University School of Medicine, NC Duke Clinical Research Institute
Daniel E SingerMassachusetts General Hospital and Harvard Medical School
Keith A A FoxUniversity of Edinburgh and Royal Infirmary of Edinburgh
Manesh R PatelDuke University School of Medicine, NC Duke Clinical Research Institute
  • 1 - 5

Datasets